Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Lupin gets USFDA nod for generic version of Arava TabletsLupin gets USFDA nod for generic version of Arava Tablets
    Granules India sells entire stake in JV Biocause PharmaGranules India sells entire stake in JV Biocause Pharma
    Cipla Q3 revenue up by 13pc at Rs 4371 croreCipla Q3 revenue up by 13pc at Rs 4371 crore
    Price-Fixing Conspiracies: Taro Pharma former executive faces probe in USPrice-Fixing Conspiracies: Taro Pharma former executive faces probe in US
    Sanofi being probed over birth defects related to Epilepsy drug DepakineSanofi being probed over birth defects related to Epilepsy drug Depakine
    JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar ChoubeyJnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey
    Granules India arm gets USFDA nod for generic version of  ValcyteGranules India arm gets USFDA nod for generic version of Valcyte
    Sun Pharma unveils acne drug Absorica LD in USSun Pharma unveils acne drug Absorica LD in US
    Cadila Healthcare Ahmedabad facility clears USFDA inspectionCadila Healthcare Ahmedabad facility clears USFDA inspection
    NPPA pulls Gilead on price exemption plea for its Hepatitis B drugNPPA pulls Gilead on price exemption plea for its Hepatitis B drug
    Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar MagnesiumZydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium
    Divis Labs Chippada facility gets zero USFDA observationsDivis Labs Chippada facility gets zero USFDA observations
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster dose to sector

    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok